NCT06090123 - Drug-Drug Interaction (DDI) Study for TPN171H | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

April 27, 2020

Study Completion Date

September 2, 2020

Conditions

Erectile Dysfunction

Interventions

DRUG

TPN171H

"Sequence 1：Single dose of 10mg TPN171H on Day 1, 200mg Itraconazole(QD) on Days 3-5, 10mg TPN171H and 200mg Itraconazole on Day 6.~Sequence 2：Single dose of 20mg TPN171H on Day 1, 600mg Rifampicin(QD) on Days 3-9, 20mg TPN171H and 600mg Rifampicin on Day 10."

DRUG

Itraconazole

Sequence 1：Single dose of 10mg TPN171H on Day 1, 200mg Itraconazole(QD) on Days 3-5, 10mg TPN171H and 200mg Itraconazole on Day 6.

DRUG

Rifampicin

Sequence 2：Single dose of 20mg TPN171H on Day 1, 600mg Rifampicin(QD) on Days 3-9, 20mg TPN171H and 600mg Rifampicin on Day 10.

Trial Locations (1)

200031

Shanghai Xuhui Central Hospital, Shanghai

All Listed Sponsors

lead

Vigonvita Life Sciences

INDUSTRY